Home > Boards > Free Zone > Health and Sciences > Biotech Values

Yes, I sold ICPT due to skepticism here,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
GrthzGd Member Profile
 
Followed By 14
Posts 1,659
Boards Moderated 1
Alias Born 09/07/10
160x600 placeholder
Top Company News of the Day
FedEx Corp., which has thrived during the coronavirus pandemic, on Thursday reported that "exceptional" growth in U.S. and international shipping propelled it to a record fourth quarter.
Nike 4Q Sales Nearly Double
Nigerian President Travels to U.K. for Medical Follow-Up
Hogs Futures Fall as U.S. Inventories Rise
Wheat Declines as Weather Turns Wetter
Front Month Nymex RBOB Gasoline Rose 0.62% to Settle at $2.2809 -- Data Talk
Front Month Nymex Natural Gas Rose 2.55% to Settle at $3.4180 -- Data Talk
Snapchat Users Gain Access to Universal Music Group's Library of Music
4D Molecular Shares Hit 52-Week Low After Roche Ends Collaboration Agreement
Pieris Pharmaceuticals Shares Rise 19% After Getting Orphan Drug Status
CAC-40 Index Ends 1.22% Higher at 6631.15 -- Data Talk
FTSE 100 Index Ends 0.51% Higher at 7109.97 -- Data Talk
STOXX Europe 50 Index Ends 0.67% Higher at 3542.88 -- Data Talk
DAX Ends 0.86% Higher at 15589.23 -- Data Talk
EURO STOXX 50 Index Ends 1.14% Higher at 4122.43 -- Data Talk
STOXX Europe 600 Index Ends 0.87% Higher at 457.04 -- Data Talk
FTSE 100 Closes Higher as Bank of England Keeps Bank Rate Unchanged
Biogen Worst Performer in S&P 500 and Nasdaq 100 So Far Today -- Data Talk
Manufacturing Activity in Central U.S. Expands Strongly in June -- Kansas City Fed
Merck Names Michael Klobuchar Chief Strategy Officer
Personal Income Seen Down 2.7% in May -- Data Week Ahead
Mortgage Rates Climb Above 3%, Freddie Mac Says
Gilead Sciences Sees Positive Results From Trial for Hepatitis Treatment
Prothena to Get $80 Million After Bristol Myers Exercises Option for Alzheimer's Treatment
Belgium Business Confidence Reaches All-Time High in June
4D Molecular Therapeutics Gets Termination Notice From Roche
FTSE 100 Builds on Gains After Bank of England Decision
GrthzGd   Tuesday, 01/06/15 10:00:07 AM
Re: DewDiligence post# 185492
Post # of 238492 
Yes, I sold ICPT due to skepticism here, and also because its continued price variance from GENFIT (even as the latter rose steadily) showed me that the ICPT price was probably still overblown.

Yes, ECYT in two lots. I had first become skeptical when you reported a surfeit of cancer treatments moving towards approval. I sold half when CHMP rejected them in February, and the rest two months later (for proceeds to buy an oil wildcatter which, luckily, I held only for a couple of weeks). I was quite lucky on ECYT, dumping it completely before MRK abrogated their partnership, for an overall profit of 118%. This was especially lucky because my original purchase decision had been upon the initial announcement of the MRK partnership.

Other sale reasons:

* GILD prior to ABBV-ENTA approval on the theory that many GILD lovers were still in denial about it.
* APRI because the concept (and the division of US vs. int'l sales) seemed more flawed the more I dug into it. (I had bought it on someone else's recommendation.)
* ENTA to take some profit and diversify a bit.

I'm a big believer in Nicholas Taleb's Black Swan theory that the avoidance of drastic loss is pretty much always a good thing. smile (Of course this didn't save me from a huge loss (mostly paper, since I had a low basis) on the GTAT bankruptcy last year.)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences